DR. MARK A MARINELLA (MD) – Medical Oncology Physician, NPI 1801888482
Medical Oncology Physician
Main info
Doctor Profile
Contacts
Profile Insights
NPPES metrics only — not quality of care.
240 MEDICAL ONCOLOGY in OH
Loading map...
Provider Addresses for DR. MARK A MARINELLA (MD)
6680 POE AVE
SUITE 200
DAYTON, OH 454142854
Phone: (937) 280-8400
Fax: (937) 280-8373
Type: Mailing
North Main Street, Englewood, Montgomery County, Ohio, 45322, United States
ENGLEWOOD, OH 454151183
Phone: (937) 293-1622
Fax: (937) 245-6308
Type: Location
8881 N Main St
Dayton, OH 454151333
Phone: (937) 293-1622
Fax: (937) 245-6308
Type: Location
2300 MIAMI VALLEY DR STE 150
CENTERVILLE, OH 454591294
Phone: (937) 293-1622
Fax: (937) 245-6308
Type: Location
6680 POE AVE STE 200
DAYTON, OH 454142855
Phone: (937) 280-8400
Fax: (937) 280-8373
Type: Mailing
3120 GOVERNORS PLACE BLVD
KETTERING, OH 454091328
Phone: (937) 293-1622
Fax: (937) 245-6308
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 249 Open Payments records for all available years, with a total value of $40,845.
Total Amount is formed as General ($40,845) + Research ($0) + Ownership ($0) = $40,845.
Last reported payment date: 2024-12-20 • Largest payer in this snapshot: GlaxoSmithKline, LLC. ($27,721).
Total Amount
$40,845
General + Research + Ownership
Payments
249
Total payment records
General Amount
$40,845
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-20
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| GlaxoSmithKline, LLC. | $27,721 |
| GENZYME CORPORATION | $2,650 |
| Novartis Pharmaceuticals Corporation | $1,913 |
| CTI BioPharma Corp. | $1,728 |
| Daiichi Sankyo Inc. | $1,314 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2009-02-16
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20090216000380 | I | Medical Oncology | OH | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 20,250 | 19 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 12,000 | 43 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 12,000 | 27 | $0 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 11,650 | 13 | $0 |
| J1756 | Injection, iron sucrose, 1 mg | 11,000 | 28 | $0 |
Insurance plans in this area (ZIP 45414)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| MEDICAL ONCOLOGY | OH | 78815 | Nuclear medicine study with CT imaging skull base to mid-thigh | 26 | 22 |
| MEDICAL ONCOLOGY | OH | 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | 226 | 97 |
| MEDICAL ONCOLOGY | OH | 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 313 | 96 |
| MEDICAL ONCOLOGY | OH | 96415 | Infusion of chemotherapy into a vein | 112 | 41 |
Group practice members
| Name | Specialty | State |
|---|---|---|
| H E M A T O L O G Y/ O N C O L O G Y | OH | |
| - | OH | |
| Radiation Oncology | OH | |
| H E M A T O L O G Y/ O N C O L O G Y | OH | |
| U R O L O G Y | OH | |
| H E M A T O L O G Y/ O N C O L O G Y | OH | |
| - | OH | |
| Nurse Practitioner | OH | |
| - | OH | |
| U R O L O G Y | OH |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.